Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis

Nature Neuroscience

Volumn 9, Issue 1, 2006, Pages 108-118

  Urushitani, Makoto ^a   Sik, Attila ^b   Sakurai, Takashi ^c   Nukina, Nobuyuki ^c   Takahashi, Ryosuke ^c   Julien, Jean Pierre ^a  

^a LAVAL UNIVERSITY   (Canada)

^b CENTRE DE RECHERCHE DE L INSTITUT UNIVERSITAIRE EN SANTÉ MENTALE DE QUÉBEC   (Canada)

^c RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; CHROMOGRANIN; MUTANT PROTEIN; SUPEROXIDE DISMUTASE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL LYSATE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; EMBRYO; GOLGI COMPLEX; IMMUNOELECTRON MICROSCOPY; MICROSOME; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECRETION; SECRETORY VESICLE; SPINAL CORD; TWO HYBRID SYSTEM; WILD TYPE;

3T3 CELLS; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; ASTROCYTES; BLOTTING, WESTERN; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; CHROMOGRANIN A; CHROMOGRANINS; COS CELLS; FLUORESCENT ANTIBODY TECHNIQUE; GLIOSIS; HUMANS; IMMUNOPRECIPITATION; INTERNEURONS; MICE; MICE, TRANSGENIC; MICROSCOPY, IMMUNOELECTRON; MICROSOMES; MOLECULAR CHAPERONES; MOTOR NEURONS; MUTATION; PLASMIDS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN FOLDING; SPINAL CORD; SUBCELLULAR FRACTIONS; SUPEROXIDE DISMUTASE;

EID: 29444443348     PISSN: 10976256     EISSN: None     Source Type: Journal    
DOI: 10.1038/nn1603     Document Type: Article

References (47)

1. Rosen, D.R. et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362, 59-62 (1993).
2. Gurney, M.E. et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264, 1772-1775 (1994).
3. Subramaniam, J.R. et al. Mutant SOD1 causes motor neuron disease independent of copper chaperone-mediated copper loading. Nat. Neurosci. 5, 301-307 (2002).
4. Wang, J., Xu, G. & Borchelt, D.R. High molecular weight complexes of mutant superoxide dismutase 1: age-dependent and tissue-specific accumulation. Neurobiol. Dis. 9, 139-148 (2002).
5. Julien, J.P. Amyotrophic lateral sclerosis, unfolding the toxicity of the misfolded. Cell 104, 581-591 (2001).
6. Cleveland, D.W. & Rothstein, J.D. From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat. Rev. Neurosci. 2, 806-819 (2001).
7. Wiedau-Pazos, M. et al. Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science 271, 515-518 (1996).
8. Raoul, C. et al. Motoneuron death triggered by a specific pathway downstream of Fas: potentiation by ALS-linked SOD1 mutations. Neuron 35, 1067-1083 (2002).
9. Durham, H.D., Roy, J., Dong, L. & Figlewicz, D.A. Aggregation of mutant Cu/Zn superoxide dismutase proteins in a culture model of ALS. J. Neuropathol. Exp. Neurol. 56, 523-530 (1997).
10. Johnston, J.A., Dalton, M.J., Gurney, M.E. & Kopito, R.R. Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA 97, 12571-12576 (2000).
11. Urushitani, M., Kurisu, J., Tsukita, K. & Takahashi, R. Proteasomal inhibition by misfolded mutant superoxide dismutase 1 induces selective motor neuron death in familial amyotrophic lateral sclerosis. J. Neurochem. 83, 1030-1042 (2002).
12. Pramatarova, A., Laganière, J., Roussel, J., Brisebois, K. & Rouleau, G.A. Neuron-specific expression of mutant superoxide dismutase 1 in transgenic mice does not lead to motor impairment. J. Neurosci. 21, 3369-3374 (2001).
13. Lino, M.M., Schneider, C. & Caroni, P. Accumulation of SOD1 mutants in postnatal motoneurons does not cause motoneuron pathology or motoneuron disease. J. Neurosci. 22, 4825-4832 (2002).
14. Clement, A.M. et al. Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 302, 113-117 (2003).
15. Shinder, G.A., Lacourse, M.C., Minotti, S. & Durham, H.D. Mutant Cu/Zn-superoxide dismutase proteins have altered solubility and interact with heat shock/stress proteins in models of amyotrophic lateral sclerosis. J. Biol. Chem. 276, 12791-12796 (2001).
16. Urushitani, M. et al. CHIP promotes proteasomal degradation of familial ALS-linked mutant SOD1 by ubiquitinating Hsp/Hsc70. J. Neurochem. 90, 231-244 (2004).
17. Taupenot, L., Harper, K.L. & O'Connor, D.T. The chromogranin- secretogranin family. N. Engl. J. Med. 348, 1134-1149 (2003).
18. Rudolf, R., Salm, T., Rustom, A. & Gerdes, H.H. Dynamics of immature secretory granules: role of cytoskeletal elements during transport, cortical restriction, and f-actin-dependent tethering. Mol. Biol. Cell 12, 1353-1365 (2001).
19. Li, J.Y., Leitner, B., Lovisetti-Scamihorn, P., Winkler, H. & Dahlström, A. Proteolytic processing, axonal transport and differential distribution of chromogranins A and B, and secretogranin II (secretoneurin) in rat sciatic nerve and spinal cord. Eur. J. Neurosci. 11, 528-544 (1999).
20. Booj, S., Goldstein, M., Fischer-Colbrie, R. & Dahlstrom, A. Calcitonin gene-related peptide and chromogranin A: presence and intra-axonal transport in lumbar motor neurons in the rat, a comparison with synaptic vesicle antigens in immunohistochemical studies. Neuroscience 30, 479-501 (1989).
21. Marksteiner, J. et al. Distribution of chromogranin B-like immunoreactivity in the human hippocampus and its changes in Alzheimer's disease. Acta Neuropathol. (Berl.) 100, 205-212 (2000).
22. Rangon, C.M. et al. Different chromogranin immunoreactivity between prion and a-beta amyloid plaque. Neuroreport 14, 755-758 (2003).
23. Schiffer, D., Cordera, S., Giordana, M.T., Attanasio, A. & Pezzulo, T. Synaptic vesicle proteins, synaptophysin and chromogranin A in amyotrophic lateral sclerosis. J. Neurol. Sci. 129 Suppl, 68-74 (1995).
24. Taupenot, L. et al. Chromogranin A triggers a phenotypic transformation and the generation of nitric oxide in brain microglial cells. Neuroscience 72, 377-389 (1996).
25. Ciesielski-Treska, J. et al. Mechanisms underlying neuronal death induced by chromogranin A-activated microglia. J. Biol. Chem. 276, 13113-13120 (2001).
26. Taylor, D.L., Diemel, L.T. & Pocock, J.M. Activation of microglial group III metabotropic glutamate receptors protects neurons against microglial neurotoxicity. J. Neurosci. 23, 2150-2160 (2003).
27. Chanat, E., Weiss, U., Huttner, W.B. & Tooze, S.A. Reduction of the disulfide bond of chromogranin B (secretogranin I) in the trans-Golgi network causes its missorting to the constitutive secretory pathways. EMBO J. 12, 2159-2168 (1993).
28. Cowley, D.J., Moore, Y.R., Darling, D.S., Joyce, P.B. & Gorr, S.U. N- and C-terminal domains direct cell type-specific sorting of chromogranin A to secretory granules. J. Biol. Chem. 275, 7743-7748 (2000).
29. Li, J.Y., Kling-Petersen, A. & Dahlstrom, A. Influence of spinal cord transaction on the presence and axonal transport of CGRP-, chromogranin A-, VIP-, synapsin I-, and synaptophysin-like immunoreactivities in rat motor nerve. J. Neurobiol. 23, 1094-1110 (1992).
30. Kato, A. et al. Co-distribution patterns of chromogranin B-like immunoreactivity with chromogranin A and secretoneurin within the human brainstem. Brain Res. 852, 444-452 (2000).
31. Stieber, A. et al. Disruption of the structure of the Golgi apparatus and the function of the secretory pathway by mutants G93A and 685R of Cu, Zn superoxide dismutase (SOD1) of familial amyotrophic lateral sclerosis. J. Neurol. Sci. 219, 45-53 (2004).
32. Ciesielski-Treska, J. et al. Chromogranin A induces a neurotoxic phenotype in brain microglial cells. J. Biol. Chem. 273, 14339-14346 (1998).
33. Huh, Y.H., Jeon, S.H. & Yoo, S.H. Chromogranin B-induced secretory granule biogenesis: comparison with the similar role of chromogranin A. J. Biol. Chem. 278, 40581-40589 (2003).
34. Turner, B.J. et al. Impaired extracellular secretion of mutant superoxide dismutase 1 associates with neurotoxicity in familial amyotrophic lateral sclerosis. J. Neurosci. 25, 108-117 (2005).
35. Jacobsson, J., Jonsson, P.A., Andersen, P.M., Forsgren, L. & Marklund, S.L. Superoxide dismutase in CSF from amyotrophic lateral sclerosis patients with and without CuZn-superoxide dismutase mutations. Brain 124, 1461-1466 (2001).
36. Sharpless, N. et al. The restricted nature of HIV-1 tropism for cultured neural cells. Virology 191, 813-825 (1992).
37. Miyakawa, K. & Imamura, T. Secretion of FGF-16 requires an uncleaved bipartite signal sequence. J. Biol. Chem. 278, 35718-35724 (2003).
38. Tiwari, A. & Hayward, L.J. Familial amyotrophic lateral sclerosis mutants of copper/zinc superoxide dismutase are susceptible to disulfide reduction. J. Biol. Chem. 278, 5984-5992 (2003).
39. Tobisawa, S. et al. Mutant SOD1 linked to familial amyotrophic lateral sclerosis, but not wild-type SOD1, induces ER stress in COS7 cells and transgenic mice. Biochem. Biophys. Res. Commun. 303, 496-503 (2003).
40. Lafon-Cazal, M. et al. Proteomic analysis of astrocytic secretion in the mouse. Comparison with the cerebrospinal fluid proteome. J. Biol. Chem. 278, 24438-24448 (2003).
41. Cimini, V. et al. CuZn-superoxide dismutase in human thymus: immunocytochemical localisation and secretion in thymus-derived epithelial and fibroblast cell lines. Histochem. Cell Biol. 118, 163-169 (2002).
42. Nickel, W. The mystery of nonclassical protein secretion. A current view on cargo proteins and potential export routes. Eur. J. Biochem. 270, 2109-2119 (2003).
43. Elam, J.S. et al. Amyloid-like filaments and water-filled nanotubes formed by SOD1 mutant proteins linked to familial ALS. Nat. Struct. Biol. 10, 461-467 (2003).
44. Nguyen, M.D., D'Aigle, T., Gowing, G., Julien, J.P. & Rivest, S. Exacerbation of motor neuron disease by chronic stimulation of innate immunity in a mouse model of amyotrophic lateral sclerosis. J. Neurosci. 24, 1340-1349 (2004).
45. Zhu, S. et al. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 417, 74-78 (2002).
46. Parkin, E.T., Hussain, I., Karran, E.H., Turner, A.J. & Hooper, N.M. Characterization of detergent-insoluble complexes containing the familial Alzheimer's disease-associated presenilins. J. Neurochem. 72, 1534-1543 (1999).
47. Stephens, D.J. & Banting, G. Direct interaction of the trans-Golgi network membrane protein, TGN38, with the F-actin binding protein, neurabin. J. Biol. Chem. 274, 30080-30086 (1999).